 |
Ayala Pharmaceuticals Announces Publication Highlighting Clinical Activity of its Gamma Secretase Inhibitor AL101 in Desmoid TumorsAyala Pharmaceuticals announced the publication of two case studies of adult patients with desmoid tumors treated with AL101 Research, News & Market Data on Ayala |
 |
CanAlaska Deals Three Uranium Projects in the Athabasca BasinCanAlaska Uranium announced it has entered into a Letter of Intent with Terra Uranium Pty Ltd, an Australian private limited corporation Research, News & Market Data on CanAlaska |
 |
CoreCivic Announces Upsizing and Pricing of Tack-On Offering of $225 Million 8.25% Senior Notes Due 2026CoreCivic announced that it successfully upsized and priced its offering See today’s research report from Joe Gomes, Senior Research Analyst at Noble Capital Markets Research, News & Market Data on CoreCivic |
 |
Gevo Acquires Butamax Patent EstateGevo announced that it has entered into an asset purchase agreement with Butamax Advanced Biofuels and its affiliate, Danisco US to acquire certain patents Research, News & Market Data on Gevo |
 |
Capstone Green Energy (NASDAQ:CGRN) Receives Two Orders for Innovative Carbon-Neutral Renewable Energy SystemsCapstone Green Energy announced that it has received two orders for externally fired microturbines through its global energy conversion partner, Professor Dr. Berg & Kießling GmbH Research, News & Market Data on Capstone Green Energy |
Stay up to date. Follow us:
|